Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Vaccine efficacy in clinical trials often exceeds real-world effectiveness due to variations in immune protection across diverse populations.
• Vulnerable groups, including children, the elderly, and those with chronic conditions, exhibit reduced vaccine responses.
• Current vaccination strategies are often population-based, but a more nuanced approach considering individual immune profiles is needed.

Purpose of the Study:

• To review the current understanding of genetic and inflammatory factors influencing antibody polyfunctionality.
• To explore how this knowledge can be applied to design precision vaccines.
• To enhance vaccine effectiveness and improve public health outcomes, particularly in vulnerable populations.

Main Methods:

• Review of existing literature on vaccine response variations.
• Analysis of genetic and inflammatory modulators of antibody polyfunctionality.
• Discussion of potential strategies for tailoring vaccine design.

Main Results:

• Vaccine response variability is influenced by immunogenetic differences and baseline health status.
• Polyfunctional antibody responses, crucial for vaccine-induced protection, are modulated in vulnerable populations.
• Key genetic and inflammatory factors significantly impact vaccination outcomes.

Conclusions:

• Next-generation vaccine development should adopt rational strategies focusing on precision medicine.
• Tailoring vaccine design based on individual immune responses, including antibody polyfunctionality, can improve protection.
• Harnessing knowledge of immune response modulators holds promise for advancing public health through more effective vaccination strategies.